- Company Directors - S
- Schaffer Derace L
Insider Trading History of Schaffer Derace L
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Schaffer Derace L since 2006.
The trader's CIK number is 1031735.
At the time of the last reporting, Schaffer Derace L was the Director of Lantheus Holdings, Inc.. (stock ticker symbol LNTH).
Also see all insider trading activities at Lantheus Holdings, Inc..
Note that in the past
SCHAFFER DERACE L also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Pharmathene Inc (PIP) by Schaffer Derace L
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2007 | PIP | 40,000 | $308,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Allion Healthcare Inc (ALLI) by Schaffer Derace L
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2006 | ALLI | 0 | $0 | 200,000 | $2,566,000 | 0 | $0 |
Yearly summary of insider trading at King Pharmaceuticals Inc (KG) by Schaffer Derace L
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2010 | KG | 10,000 | $89,500 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at American Caresource Holdings, Inc. (ANCI) by Schaffer Derace L
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2012 | ANCI | 56,032 | $30,787 | 0 | $0 | 0 | $0 |
| 2011 | ANCI | 88,508 | $50,015 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Altimmune, Inc. (ALT) by Schaffer Derace L
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | ALT | 97,410 | $187,432 | 0 | $0 | 0 | $0 |
| 2017 | ALT | 387,665 | $756,046 | 0 | $0 | 20,000 | $44,000 |
| 2016 | ALT | 0 | $0 | 0 | $0 | 130,000 | $240,500 |
| 2011 | ALT | 37,702 | $26,391 | 267,497 | $986,948 | 0 | $0 |
| 2010 | ALT | 100,000 | $148,509 | 0 | $0 | 0 | $0 |
| 2009 | ALT | 50,000 | $60,000 | 230,549 | $0 | 0 | $0 |
| 2007 | ALT | 240,000 | $1,817,600 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Lantheus Holdings, Inc. (LNTH) by Schaffer Derace L
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | LNTH | 0 | $0 | 40,000 | $969,560 | 0 | $0 |
| 2017 | LNTH | 0 | $0 | 40,000 | $650,250 | 0 | $0 |
Insider trading activities at 6 companies by Schaffer Derace L:
1. Pharmathene Inc (PIP)
2. Allion Healthcare Inc (ALLI)
3. King Pharmaceuticals Inc (KG)
4. American Caresource Holdings, Inc. (ANCI)
5. Altimmune, Inc. (ALT)
6. Lantheus Holdings, Inc. (LNTH)
Table 1. Insider trading of Pharmathene Inc (PIP) by Schaffer Derace L
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2007-08-07 | PIP | Buy | 40,000 | 7.70 | 308,000 |
Table 2. Insider trading of Allion Healthcare Inc (ALLI) by Schaffer Derace L
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2006-01-31 | ALLI | Sale | 200,000 | 12.83 | 2,566,000 |
Table 3. Insider trading of King Pharmaceuticals Inc (KG) by Schaffer Derace L
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2010-05-14 | KG | Buy | 10,000 | 8.95 | 89,500 |
Table 4. Insider trading of American Caresource Holdings, Inc. (ANCI) by Schaffer Derace L
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2012-06-18 | ANCI | Buy | 100 | .55 | 55 |
| 2012-06-14 | ANCI | Buy | 1,662 | .55 | 914 |
| 2012-06-15 | ANCI | Buy | 500 | .55 | 275 |
| 2012-06-11 | ANCI | Buy | 2,000 | .55 | 1,098 |
| 2012-06-12 | ANCI | Buy | 12,000 | .55 | 6,588 |
| 2012-06-13 | ANCI | Buy | 16,000 | .55 | 8,784 |
| 2012-03-29 | ANCI | Buy | 20,200 | .55 | 11,110 |
| 2012-03-30 | ANCI | Buy | 3,570 | .55 | 1,963 |
| 2011-12-19 | ANCI | Buy | 300 | .39 | 117 |
| 2011-12-21 | ANCI | Buy | 3,434 | .39 | 1,339 |
| 2011-12-12 | ANCI | Buy | 15,900 | .39 | 6,201 |
| 2011-12-14 | ANCI | Buy | 17,099 | .39 | 6,668 |
| 2011-12-08 | ANCI | Buy | 1,625 | .39 | 633 |
| 2011-12-09 | ANCI | Buy | 150 | .39 | 58 |
| 2011-08-29 | ANCI | Buy | 12,298 | .70 | 8,608 |
| 2011-08-25 | ANCI | Buy | 16,800 | .70 | 11,760 |
| 2011-08-24 | ANCI | Buy | 20,902 | .70 | 14,631 |
Table 5. Insider trading of Altimmune, Inc. (ALT) by Schaffer Derace L
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-12-28 | ALT | Buy | 58,711 | 1.92 | 112,666 |
| 2017-12-29 | ALT | Buy | 38,699 | 1.93 | 74,766 |
| 2017-12-22 | ALT | Buy | 17,982 | 1.61 | 28,879 |
| 2017-12-26 | ALT | Buy | 51,442 | 1.81 | 93,264 |
| 2017-12-27 | ALT | Buy | 77,706 | 1.77 | 137,306 |
| 2017-12-07 | ALT | Buy | 7,639 | 1.74 | 13,307 |
| 2017-12-06 | ALT | Buy | 16,106 | 1.80 | 28,990 |
| 2017-12-05 | ALT | Buy | 13,495 | 1.78 | 23,994 |
| 2017-12-01 | ALT | Buy | 5,215 | 1.80 | 9,402 |
| 2017-12-04 | ALT | Buy | 7,300 | 1.81 | 13,198 |
| 2017-11-28 | ALT | Buy | 12,395 | 1.97 | 24,442 |
| 2017-11-29 | ALT | Buy | 7,942 | 1.94 | 15,375 |
| 2017-11-30 | ALT | Buy | 12,978 | 1.83 | 23,814 |
| 2017-11-27 | ALT | Buy | 10,042 | 2.00 | 20,063 |
| 2017-11-24 | ALT | Buy | 6,505 | 2.02 | 13,159 |
| 2017-11-22 | ALT | Buy | 5,261 | 2.10 | 11,058 |
| 2017-11-21 | ALT | Buy | 7,236 | 2.06 | 14,906 |
| 2017-11-17 | ALT | Buy | 6,295 | 2.12 | 13,351 |
| 2017-11-20 | ALT | Buy | 4,800 | 2.08 | 9,960 |
| 2017-08-24 | ALT | Buy | 17,326 | 2.25 | 38,896 |
| 2017-08-25 | ALT | Buy | 50,000 | 2.25 | 112,400 |
| 2017-08-23 | ALT | Buy | 43,352 | 2.22 | 96,371 |
| 2017-08-22 | ALT | Buy | 5,958 | 2.10 | 12,517 |
| 2017-08-21 | ALT | Buy | 690 | 2.02 | 1,394 |
| 2017-01-13 | PIP | Option Ex | 20,000 | 2.20 | 44,000 |
| 2016-09-30 | PIP | Option Ex | 130,000 | 1.85 | 240,500 |
| 2011-08-25 | PIP | Buy | 16,800 | .70 | 11,760 |
| 2011-08-24 | PIP | Buy | 20,902 | .70 | 14,631 |
| 2011-05-17 | PIP | Sale | 75,000 | 3.71 | 278,325 |
| 2011-05-18 | PIP | Sale | 50,000 | 3.68 | 183,950 |
| 2011-05-19 | PIP | Sale | 142,497 | 3.68 | 524,673 |
| 2010-05-18 | PIP | Buy | 83,253 | 1.50 | 124,712 |
| 2010-05-17 | PIP | Buy | 16,747 | 1.42 | 23,797 |
| 2009-12-11 | PIP | Buy | 50,000 | 1.20 | 60,000 |
| 2009-03-26 | PIP | Sale | 17,735 | .00 | 0 |
| 2009-03-12 | PIP | Sale | 212,814 | .00 | 0 |
| 2007-08-07 | HAQ | Buy | 40,000 | 7.70 | 308,000 |
| 2007-08-03 | HAQ | Buy | 100,000 | 7.55 | 755,000 |
| 2007-05-16 | HAQ | Buy | 10,000 | 7.54 | 75,400 |
| 2007-05-15 | HAQ | Buy | 10,000 | 7.54 | 75,400 |
| 2007-05-14 | HAQ | Buy | 10,000 | 7.54 | 75,400 |
| 2007-05-11 | HAQ | Buy | 10,000 | 7.55 | 75,500 |
| 2007-05-09 | HAQ | Buy | 10,000 | 7.54 | 75,400 |
| 2007-05-10 | HAQ | Buy | 10,000 | 7.55 | 75,500 |
| 2007-05-08 | HAQ | Buy | 10,000 | 7.55 | 75,500 |
| 2007-05-07 | HAQ | Buy | 10,000 | 7.55 | 75,500 |
| 2007-05-03 | HAQ | Buy | 10,000 | 7.55 | 75,500 |
| 2007-05-04 | HAQ | Buy | 10,000 | 7.55 | 75,500 |
Table 6. Insider trading of Lantheus Holdings, Inc. (LNTH) by Schaffer Derace L
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-06-05 | LNTH | Sale | 10,000 | 24.71 | 247,130 |
| 2019-06-03 | LNTH | Sale | 10,000 | 23.47 | 234,730 |
| 2019-06-04 | LNTH | Sale | 10,000 | 24.36 | 243,610 |
| 2019-04-01 | LNTH | Sale | 10,000 | 24.41 | 244,090 |
| 2017-09-12 | LNTH | Sale | 10,000 | 17.50 | 175,000 |
| 2017-09-13 | LNTH | Sale | 5,000 | 17.50 | 87,500 |
| 2017-05-12 | LNTH | Sale | 5,000 | 16.55 | 82,750 |
| 2017-05-10 | LNTH | Sale | 10,000 | 15.75 | 157,500 |
| 2017-05-09 | LNTH | Sale | 10,000 | 14.75 | 147,500 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Schaffer Derace L
(Director of Lantheus Holdings, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.